Cite

HARVARD Citation

    Driessens, G. et al. (n.d.). Preclinical assessment of a novel small molecule inhibitor of indoleamine 2, 3-dioxygenase 1 (IDO1). Journal for immunotherapy of cancer. p. . [Online]. 
  
Back to record